The firm's stent helps less the risk of embolisms.
Angioplasty products start-up Angioslide Ltd. has raised $8.6 million from Itochu Corporation (TSE:8001) of Japan and two previous investors, Ofer Hi Tech Ltd. and Viola. The company is a graduate of Ofer Hi Tech's Naiot Venture Accelerator.
AngioSlide was founded by Dr. Yoav Turgeman in 2005. Its CEO is Dr. Doron Besser. The company is developing a balloon dilatation catheter for cardiovascular angioplasty with the possibility for debris removal. This process enables one stent to perform two procedures, thereby shortening the duration of the angioplasty and reducing costs and the risk of embolisms. The company has obtained EU CE Mark certification for its product for use in the legs and expects to obtain US Food and Drug Administration (FDA) approval by the end of this year. The company plans to launch its product in Western Europe within three months.
Published by Globes [online], Israel business news - www.globes-online.com - on May 28, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008